| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.00095 | 1 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.00068 | 1 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.00055 | 1 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.0006 | 1 |